News

News

The most innovative start-up of the year 2017 at Biofit

The most innovative start-up of the year 2017 at Biofit

Friday, December 01st 2017

Vaxinano has been awarded with the most innovative start-up prize by the steering committee of BioFit 2017 in the start-up slams competition

...Read more

Vaxinano develops the first vaccine against toxoplasmosis

Vaxinano develops the first vaccine against toxoplasmosis

05/09/2017

Visit the website Download the article

'coup de coeur' price

'coup de coeur' price

Thursday, April 27th 2017

Vaxinano wins the 'coup de coeur' price from KPMG / Invest'Innove

...Read more

New funding

New funding

Wednesday, April 12th 2017

Vaxinano has obtained funding from the British government to evaluate its technology for a Zika vaccine

...Read more

New funding

New funding

Monday, March 27th 2017

Vaxinano has obtained funding from Bpifrance for the evaluation of 2 vaccine candidates

...Read more

Vaxinano, the biotech company that change the story

Vaxinano, the biotech company that change the story

27/03/2017

Visit the website Download the article

Invest'Innov links start-up and funders

Invest'Innov links start-up and funders

22/03/2017

Visit the website Download the article

No more stings with Vaxinano

No more stings with Vaxinano

20/03/2017

Visit the website Download the article

The tomorrow's non-toxic vaccines

The tomorrow's non-toxic vaccines

15/03/2017

Visit the website Download the article

Vaxinano at the front page of La Voix du Nord

Vaxinano at the front page of La Voix du Nord

15/03/2017

Visit the website Download the article

New contract

New contract

Monday, March 13rd 2017

Vaxinano has signed a new research contract with a second industrial partner, a world leader in the animal health industry

...Read more

sub-licence

sub-licence

Monday, February 20th 2017

Vaxinano signs a third exclusive licence of exploitation for patent with SATT Nord related to the vaxinano technology.

...Read more